Current approaches in gestational diabetes mellitus

Gestational diabetes mellitus (GDM) is one of the most common medical complications in pregnancy and has become a global public health issue in terms of causing fetal and maternal morbidity and mortality in short- and long-term. The number of cases of GDM all over the world has been increasing day by day and they include risks for mother and baby health compared to healthy pregnancies. GDM screening and diagnostic phase has complete different approaches and there is no common consensus. Once GDM is diagnosed, pharmacologic treatment can be necessary in addition to strict blood sugar follow-up, regular exercise, and diet regulation. In postpartum period, medical monitoring is also necessary due to increased risk of diabetes mellitus in women with GDM. In this paper, we will also discuss approaches suggested in the GDM in the context of current guidelines and literature.

Keywords:

Hyperglycemia pregnancy, gestational diabetes mellitus, current approaches,

PDF

___

[1] Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013;122(2 Pt 1):406-16.
[2] Murthy KS, Bhandiwada A, Chandan SL, Gowda SL, Sindhusree, G. Evaluation of oxidative stress and proinflammatory cytokines in gestational diabetes mellitus and their correlation with pregnancy outcome. Indian J Endocrinol Metab 2018;22:79-84.
[3] Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 2012;25:600-10.
[4] Ozcimen EE, Uckuyu A, Ciftci FC, Yanık FF, Bakar C. Diagnosis of gestational diabetes mellitus by use of the homeostatis model assessment insulin resistance index in the first trimester. Gynecol Endocrinol 2008;24:224-49.
[5] Ozyurt R, Asicioglu O, Gultekin T, Gungorduk K, Boran B. The prevalance of gestational diabetes mellitus in pregnant women who were admitted to İstanbul teaching and research hospital obstetric and gynecology department. JOPP Derg 2013;5:7-12.
[6] Gurel C, Ozgun MT, Batukan C, Bagbug M. Prevalence of gestational diabetes among pregnant women attending Erciyes University medical faculty. Erciyes Med J 2009;31:323-30.
[7] Catalano PM, Kirwan JP, Mouzonz SH, Janet Kingz. Gestational diabetes and insulin Resistance: role in short and long term implications for mother and fetus. J Nutr 2003;133:1674-83.
[8] Desoye G, Kaufmann P. The human placenta in diabetes. In: Diabetology of Pregnancy. Djelmis J, Desoye G, Ivanisevic M. eds., Front Diabetes. Basel, Karger, 2005, vol. 17, pp. 94-109.
[9] Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-16.
[10] Desoye G, Hauguel-de Mouzon S, Shafrir E. The Placenta in diabetic pregnancy. In: Hod M, Jovanovic L, Di Renzo G, de Leiva A, Langer O. Textbook of Diabetes and Pregnancy. New York: Martin Dunitz, 2003;126-49.
[11] Hassiakos D, Eleftheriades M, Papastefanou I, Lambrinoudaki I, Kappou D, Lavranos D, et al. Increased maternal serum interleukin-6 concentrations at 11 to 14 weeks of gestation in low risk pregnancies complicated with gestational diabetes mellitus: development of a prediction model. Horm Metab Res 2016;48:35-41.
[12] Buchanan TA, Xiang AH, Kjos SL, Watanabe RM. What is gestational diabetes? Diab Care 2007;30:105-11.
[13] Gloyn AL, Siddiqui J, Ellard S. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2006;27:220-31.
[14] HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
[15] Fridlyand LE, Philipson LH. Reactive species, cellular repair, and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr Diabetes Rev 2006;2:241-59.
[16] Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis. PloS One 2014;9:e92485.
[17] Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet 1996;347:227-30.
[18] Salzer L, Yogev Y. Complications of gestational diabetes. In: Petry CJ, editor. Gestational diabetes: Origins, complications, and treatment. Chapter 5. Boca Raton: CRC Press. USA: Taylor and Francis Group, 2014;95-109.
[19] Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-92.
[20] Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med 2014;60:695-703.
[21] Dirar AM, Doupis J. Gestational diabetes from A to Z. World J Diabetes 2017;8:489-511.
[22] Girz B, Divon M, Merkatz I. Sudden fetal death in women with well-controlled intensively monitored gestational diabetes. J Perinatol 1992;12:229-33.
[23] Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Eng J Med 2005;352:2477-86.
[24] American Diabetes Association. 13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:137-43.
[25] Anuk İnce D, Takcı S, Gumuser R. The newborn period problems of the infants born to diabetic mothers. J Contemp Med 2014;4:115-20.
[26] Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet 2009;104:25-6.
[27] Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078-83.
[28] Satman İ, İmamoglu S, Yılmaz C. TEMD Diabetes mellitus ve komplikasyonlarının tanı, tedavi ve izlem kılavuzu. 4. Baskı, Bayt Bilimsel Arastırmalar Basın Yayın Tanıtım Ltd. Sti. Ankara, 2009.
[29] International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
[30] American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes 2015;33 97-111.
[31] Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes 2017;9:320-24.
[32] Koivusalo SB, Rono K, Klemetti MM, Roine RP, Lindstrom J, Erkkola M, et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: The finnish gestational diabetes prevention study (RADIEL): A Randomized Controlled Trial. Diabetes Care 2016;39:24-30.
[33] Nascimento SL, Surita FG, Cecatti JG. Physical exercise during pregnancy: a systematic review. Curr Opin Obstet Gynecol 2012;24:387-94.
[34] ACOG Practice Bulletin No. 190 Summary: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131:406-8.
[35] Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-aalysis. BMJ 2015;21:h102.
[36] Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN, Su SW. Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2015;100:2071-80.
[37] Castillo WC, Boggess K, Sturmer T, Brookhart MA, Benjamin DK, Funk MJ. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr 2015;169:452-8.
[38] Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New Eng J Med 2007;356:551-66.
[39] Camelo Castillo W, Boggess K, Sturmer T, Brookhart MA, Benjamin DK, Jonsson Funk M. Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes. JAMA Pediatr 2015;69:452-8.
[40] National Institute for Health and Care Excellence (NICE). Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. Clinical guideline NG3 (2015); 2015. Available from: www.nice.org.uk/guidance/ng3/resources/diabetes-in-pregnancy-management-of-diabetes-and-itscomplications-from-preconception-to-the-postnatal-period-51038446021.
[41] International Diabetes Federation (IDF) Clinical Guidelines Task Force. Global guideline on pregnancy and diabetes. Brussels: International Diabetes Federation; 2009.
[42] Blumer I, Hadar E, Hadden DR, Jovanovič L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. JCEM 2013;98:4227-49.
[43] Ryu RJ, Hays KE, Hebert MF. Gestational diabetes mellitus management with oral hypoglycemic agents. Semin Perinatol 2014;38:508-15.